Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Archer-Daniels-Midland Co (ADM) vs AdaptHealth Corp (AHCO) Price & Performance

Archer-Daniels-Midland CoTrade
AdaptHealth CorpTrade

Price performance (Past 24H)

Key statistics

Archer-Daniels-Midland Co vs AdaptHealth Corp — how do they compare? Archer-Daniels-Midland Co trades at $80.37 (market cap $38.78B), while AdaptHealth Corp trades at $5.77 (market cap $753.09M). The key difference: Archer-Daniels-Midland Co is far larger — about 51.5× AdaptHealth Corp's market cap, and Archer-Daniels-Midland Co pays a 2.59% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.

ADMAHCO
Market Cap
$38.78B$753.09M
Sector
Consumer StaplesHealth
52-Week High
$87.32$13.38
52-Week Low
$56.00$5.22
Enterprise Value
$47.03B$2.77B
Dividend Yield
2.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Archer-Daniels-Midland Co

ADM trades at $79.41, down 1.34% today, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.84, exceeding expectations, and raised its full-year outlook, driven by biofuels and crushing margins. Valuation ratios like P/E of 21.98 and P/S of 0.48 suggest reasonable pricing relative to peers. Cash flow improved in 2025 with net cash flow of $1.58 billion.

The outlook is positive with analyst consensus price target of $88.00, implying upside. Key opportunities include growth in AgTech and biofuels, while risks involve execution challenges and volatile commodity markets. The stock offers a dividend yield supported by consistent payments, but investors should monitor margin pressures from input costs.

AdaptHealth Corp

AdaptHealth Corp. (AHCO) trades at $5.74, up 9.96% in the last session, yet remains under pressure with a bearish technical signal and recent earnings misses. The company reported a Q2 2026 net loss of $228 million with a -6.82% margin, while selling its diabetes unit to focus on sleep and respiratory care. Valuation ratios show a low P/S of 0.23 and P/B of 0.55, but negative profitability metrics highlight operational challenges.

The outlook is mixed: analyst consensus is bullish with a $11 price target, but risks include ongoing losses, fraud investigations, and cost overruns in fixed-price contracts. Upside depends on successful business restructuring and margin improvement, while downside risks from legal and execution issues persist.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Archer-Daniels-Midland Co

Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. Additionally, the company owns an extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients. The company is also a large producer of corn-based sweeteners, starches, and ethanol.

Read more on ADM

About AdaptHealth Corp

AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.

Read more on AHCO